Clinical Trials Currently Open

659-599-1847

Clinical Research Trials

Research Studies for Dermatologic Conditions

Advanced Dermatology and Cosmetic Surgery is a multi-state dermatology practice with more than 155 locations nationwide. The Clinical Research Division was founded to find new and better ways to treat patients with dermatologic conditions through FDA-supervised clinical trials of leading-edge drugs, devices and other treatments.

Psoriasis Online Research Study

Males and Females, Ages 18+. Qualifying patients will have a diagnosis of psoriasis and must be able to speak fluently in English and must be under the care of an Advanced Dermatology and Cosmetic Surgery (or any other member of the Advanced Dermatology brand family) provider. 

Psoriasis is a chronic inflammatory skin condition that affects 2-3% of US adults. Psoriasis has a significant impact on patients’ lives, even when mild. It can be itchy or painful and in severe cases can crack and bleed.  

Study Overview

To enroll, click here to provide consent and sign up.

 

Study Details

In partnership with the Arthritis Research Foundation, Advanced Dermatology and Cosmetic Surgery is requesting participation of patients who have been diagnosed with Psoriasis in this registry. The primary objective of this study is to identify risk factors for the development of cardiovascular disease, diabetes, and PsA among patients with psoriasis.  There is no cost to participate, and insurance is not required. Qualified participants will be under the supervision of a board-certified dermatologist.

Compensation: up to $200
Duration: 2 Years
Visits: none, participants will complete 4 questionnaires online during the 2 year period

Melanoma Chart Review Study

Males and Females, Ages 18 - 90.  Qualifying patients have or have had melanoma skin cancer.

Melanoma skin cancer is a type of skin cancer originating from melanocytes, the cells that produce pigment. The Decision DX Melanoma diagnostic test is used to assess the risk of metastasis and recurrence in patients with melanoma by analyzing the tumor's genetic profile.    

Submit Your Interest

 

Study Details

Participating patients must be diagnosed with Melanoma skin cancer with a Decision DX melanoma diagnostic test. This is a Melanoma chart review study, a research method involving the analysis of medical records (charts) of patients diagnosed with melanoma. The goal is to gather and evaluate data on patient demographics, treatment outcomes, disease progression, and other relevant clinical information to draw conclusions about the effectiveness of treatments, patient prognoses, or trends in melanoma care.

Compensation: TBD
Duration: 10 year study, chart review every 6 months
Visits: none

 

Research Studies at Warren, Michigan

Grekin Skin Institute-Warren
​13450 E. 12 Mile Road
Warren, MI 48088

The following clinical trials, under the direction of Dr. Steven Grekin, are open and requesting participants who live in or near Warren or can travel here. Dr. Grekin, founder of The Grekin Skin Institute, has been involved in Clinical Research for drug and device development since 2002. He continues a family legacy of providing extraordinary dermatologic care and treatment which dates back through more than 100 years of physicians, including seven dermatologists.

 

Chronic Urticaria (Itch)

Males and Females, Ages 18+.  Qualifying patients will have Chronic Urticaria.

Chronic urticaria is a condition characterized by the presence of hives, or wheals, on the skin that last for more than six weeks, often accompanied by itching and swelling. 

Submit Your Interest

 

Study Details

A Phase 3 randomized, double-blind, placebo-controlled study to assess the efficacy and safety of Barzolvolimab in patients with Chronic Spontaneous Urticaria who remain symptomatic despite H1 Antihistamine Treatment.

Compensation: up to $1,600
Duration: 68 weeks
Visits: 19

 

Hidradenitis Suppurativa (Acne Inversa)

Males and Females, Ages 18+.  Qualifying patients will have moderate to severe Hidradenitis Suppurativa.

Hidradenitis suppurativa is a chronic inflammatory skin condition characterized by painful, swollen lumps that can rupture and cause abscesses, often occurring in areas where skin rubs together, such as the armpits, groin, and under the breasts. 

Submit Your Interest

 

Study Details

A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe Hidradenitis Suppurativa.  Subcutaneous sonelokimab is a type of monoclonal antibody administered via injection under the skin, designed to target and inhibit specific proteins involved in an inflammatory response.

Compensation: up to $1,400
Duration: 56 weeks
Visits: 20

 

Androgenetic Alopecia (male pattern baldness)

Males only, Ages 18+.  Qualifying patients will have male pattern baldness.

Androgenetic Alopecia, also known as male pattern baldness, is a genetically predetermined disorder due to an excessive response to androgens and is characterized by progressive loss of hair of the scalp any time after puberty. 

Submit Your Interest

 

Study Details

During the clinical trial, participants should expect the following:

  • Blood samples will be taken approx. 6 times
  • A hair diagnosis (on a chosen area of the scalp with a diameter of a small coin where hairs will be clipped to approximately 1mm in length) by means of standardized photographs
  • Investigational product application topically to the balding areas will be performed at home

There is no cost to participate, and insurance is not required. Qualified participants will be under the supervision of a board-certified dermatologist.

Compensation: up to $250
Duration: 14 months
Visits: 8 out-patient visits at the Grekin Skin Institute in Warren and 2 phone calls with the site study staff within the 14 months study time-frame

 

Atopic Dermatitis (Eczema)

Males and Females, Ages 18 and up.  Qualifying patients will have moderate to severe atopic dermatitis (eczema). 

Atopic dermatitis, also known as eczema, is a chronic, inflammatory skin condition that's common in young children, but can occur at any age. It may cause itchiness, dry skin, rashes, scaly patches, thickening of the skin, blisters, and skin infections. This condition can weaken your skin’s barrier function, which helps your skin retain moisture and protects your body from outside elements. While there is no cure for eczema, dermatologists specialize in managing its symptoms through various treatments.

Submit Your Interest

 

Study Details

Grekin Skin Institute is enrolling adults for a double-blind, randomized, placebo treatment controlled study. The study will last 16 weeks with an 8-week follow up. There is no cost to participate, and insurance is not required. Qualified participants will be under the supervision of a board-certified dermatologist and receive up to $1,300 compensation for time and travel.

Compensation: $1,300
Duration: 24 Weeks
Visits: 10

 

Psoriasis

Males and Females, Ages 18 and up. Qualifying patients will have moderate to severe plaque psoriasis. 

Plaque psoriasis is the most common type and is characterized by dry, red and raised lesions (called plaques) that are covered with silvery white buildup of dead skin cells. The itchy and sometimes painful plaques often form on the scalp, elbows, knees and lower back, though they can appear anywhere on the body. When something causes psoriasis to flare-up, skin cells grow abnormally fast ­– in just days instead of weeks. The result is a buildup of cells and thick patches of red skin with silvery scales that can flake off like dandruff. 

Submit Your Interest

 

Study Details

Grekin Skin Institute is enrolling adults for a Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis. The study will last for up to 1 year. There is no cost to participate, and insurance is not required. Qualified participants will be under the supervision of a board-certified dermatologist and receive up to $2,025 compensation for time and travel.

Compensation: $2,025
Duration: 56 Weeks
Visits: 18

Research Studies at Spartanburg, South Carolina

Advanced Dermatology and Cosmetic Surgery
1650 Skylyn Dr, Ste 402
Spartanburg, SC 29307

 

Androgenetic Alopecia (male pattern baldness)

Males only, Ages 18+.  Qualifying patients will have male pattern baldness.

Androgenetic Alopecia, also known as male pattern baldness, is a genetically predetermined disorder due to an excessive response to androgens and is characterized by progressive loss of hair of the scalp any time after puberty. 

Submit Your Interest

 

Study Details

During the clinical trial, participants should expect the following:

  • Blood samples will be taken approx. 6 times
  • A hair diagnosis (on a chosen area of the scalp with a diameter of a small coin where hairs will be clipped to approximately 1mm in length) by means of standardized photographs
  • Investigational product application topically to the balding areas will be performed at home

There is no cost to participate, and insurance is not required. Qualified participants will be under the supervision of a board-certified dermatologist.

Compensation: up to $250
Duration: 14 months
Visits: 8 out-patient visits at the Grekin Skin Institute in Warren and 2 phone calls with the site study staff within the 14 months study time-frame

 

Join Clinical Trials

To learn more about our clinical trials or to participate in current or future trials, please complete the form.

Acceptance in our clinical trials may sometimes require travel to the research facility to participate. Are you willing to travel?*

In the News

In the past, our clinical study results indicated that more than one million skin cancers went undiagnosed in 2020 as a result of COVID-19 concerns, and that total-body skin cancer exams are the most effective way to find skin cancers were published nationally in the January 19, 2021 edition of the Journal of the American Academy of Dermatology (JAAD) and Journal of Clinical Oncology®, an American Society of Clinical Oncology (ASCO) Journal.

 

About Us

What We Do, Our Mission, and Research Investigators

LEARN MORE

 

 

Sponsors and CROs

Reasons to Partner With Us on Clinical Trials

LEARN MORE

 

Locations

Advanced Dermatology and
Cosmetic Surgery
1650 Skylyn Dr, Ste 402
Spartanburg, SC 29307

Grekin Skin Institute
Part of Advanced Dermatology and Cosmetic Surgery
13450 E. 12 Mile Rd.
Warren, Michigan 48088

Added to Cart​

Checkout​

Images are loading, please wailt a minute.

Thank you for reaching out. Our staff will contact you within 24 hours!
Cannot submit your request. Please try again later
close popup